Kristie Kuhl Named One Of The 2017 PM360 ELITE 100; Tapped As A PM360 Transformational Leader

News provided by

May 23, 2017, 10:00 ET

NEW YORK, May 23, 2017 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical and medical device sectors, has named Kristie Kuhl, JD, senior partner, Finn Partners, as one of the 2017 PM360 ELITE 100 in the Transformational Leader category. Now in its third year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) award represents the most influential people in the healthcare industry today. https://www.pm360online.com/elite-transformational-leader-kristie-kuhl-of-finn-partners/

Kuhl serves as head of the Finn Partners New York Health Group, and champions the Agency's pharmaceutical sector efforts. Trained as an attorney, she began her career as head of a cancer patient advocacy group, and went on to serve executive roles at Makovsky and Cohn & Wolfe before joining Finn Partners. Always placing the patient at the center of communication efforts, she serves on the CancerCare (Connecticut) board and is a member of the development committee for the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation.

"There are many healthcare PR leaders; Kristie's experience and values-driven leadership ability set her apart," said Gil Bashe, managing partner and Global Health Practice leader, Finn Partners. "To transform our health team into a world-class Practice, we knew that ideas, insight, and integrity were integral to our clients' success and colleagues' development. Kristie understands that growth is an outcome of doing the right thing, for clients and colleagues, and reflects our mission to improve patient care."

The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact to the healthcare industry throughout their careers. More than 500 submissions were received and nominees were evaluated based on their accomplishments. A total of 100 winners were selected across 18 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.

"Each of the 2017 PM360 ELITE 100 demonstrate immense talent in their ability to impact our industry," says Anna Stashower, CEO and Publisher of PM360. "These people represent the best the industry has to offer, including veterans who have made their mark over and over and up-and-comers who are just getting started."

About Finn Partners, Inc.

Founded in 2011 on the core principles of innovation and collaborative partnership, Finn Partners has tripled in size in just five years, becoming one of the fastest growing independent public relations agencies in the world. The full-service marketing and communications company's record setting pace is a result of organic growth and integrating new companies and new people into the Finn Partners world through a common philosophy. Finn Partners' mantra, Work Hard, Play Nice, infuses internal and external relationships, resulting in amazing work and an all-inclusive environment. With 540 professionals, Finn Partners provides its clients with global access and capabilities in the U.S., Europe and Asia, in addition to PROI Worldwide. Headquartered in New York, Finn Partners' other offices are located in: Chicago, Detroit, Fort Lauderdale, Jerusalem, London, Los Angeles, Munich, Nashville, Paris, Portland, San Francisco, Singapore and Washington D.C. Find us at finnpartners.com and follow us on Twitter @finnpartners.

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

Contacts:
[email protected] 212-715-1600
[email protected] 646-300-8111

SOURCE Finn Partners